Tag Archives: england journal of medicine

One Step toward Personalized Bronchial asthma Treatment

by on 01. Oct, 2011 in Health

Fresh England Journal of drugs, Volume 365, Problem 13, Sheet 1245-1246, September 2011. (Source: Fresh England Journal of drugs)

MedWorm Sponsor Message: Please pay attention to this plea of support for the health workers in Bahrain. #FreeDoctors

More details: More info...

Tags: Health, Journal, div id, england journal of medicine, self…

Read full story • Comments { 0 }

Adding LABAs to Breathed in Glucocorticoids for Bronchial asthma

by on 01. Oct, 2011 in Health

Fresh England Journal of drugs, Volume 365, Problem 13, Sheet 1260-1261, September 2011. (Source: Fresh England Journal of drugs) More details: Mornfos...

Tags: labas, Health, journal of medicine, Sheet, glucocorticoids, england journal of medicine…

Read full story • Comments { 0 }

Genomewide Association between GLCCI1 and Reaction to Glucocorticoid Therapy in Bronchial asthma

by on 01. Oct, 2011 in Health

Fresh England Journal of drugs, Volume 365, Problem 13, Sheet 1173-1183, September 2011. (Source: Fresh England Journal of drugs) More details: Informtions...

Tags: england journal of medicine, asthma, association, Health, Source, England…

Read full story • Comments { 0 }

Bronchial asthma Phenotypes and Interleukin-13 — Moving Nearer to Personalized Medicine

by on 04. Sep, 2011 in Health

Fresh England Journal of drugs, Volume , Problem , In front of Print. (Source: Fresh England Journal of drugs) More details: Informations...

Tags: england journal of medicine, asthma, medicine, Health, phenotypes, interleukin…

Read full story • Comments { 0 }

Roche's investigational treatment for asthma met its primary endpoint in a phase II study

by on 07. Aug, 2011 in Health

Roche today introduced that the phase II study of their investigational treatment lebrikizumab, a humanized monoclonal antibody made to block interleukin-13 (IL-13) cytokine, met its primary endpoint. Within the study, lebrikizumab treatment led to a statistically significant rise in FEV1 (way of measuring breathing) in grown ups with bronchial asthma whose signs and symptoms were improperly controlled with breathed in corticosteriods (ICS). The entire frequency of adverse occasions was alike both in the placebo and also the treatment collection. The outcomes of the study, referred to as &16MILLY̵ are now being released within the Fresh England Journal of drugs (NEJM) …

Read full story • Comments { 0 }

Lebrikizumab Treatment in Grown ups with Bronchial asthma

by on 04. Aug, 2011 in Health

Fresh England Journal of drugs, Volume , Problem , In front of Print. (Source: Fresh England Journal of drugs) More details: Check this...

Tags: Ahead, Health, medicine, england journal of medicine, Print, Fresh…

Read full story • Comments { 0 }

Effect of Bronchoconstriction on Airway Remodeling in Asthma

by on 28. May, 2011 in Health

Fresh England Journal of Medicine, Volume 364, Problem 21, Sheet 2006-2015, Might 2011. (Supply: Fresh England Journal of Medicine) More information: More info...

Tags: bronchoconstriction, asthma, england journal of medicine, medicine, Fresh, Health…

Read full story • Comments { 0 }

Leukotriene Antagonists as Initial-Line or Add-on Asthma-Controller Therapy

by on 06. May, 2011 in Health

Fresh England Journal of Medicine, Volume 364, Problem 18, Sheet 1695-1707, May 2011. (Supply: Fresh England Journal of Medicine) More information: Click here...

Tags: medicine, Health, volume, antagonists, Sheet…

Read full story • Comments { 0 }

Leukotriene antagonists as first-line or add-on asthma-controller therapy: findings of two pragmatic trials

by on 06. May, 2011 in Health

Supply: N Engl J Med
Region: News
Data from RCTs have indicated usually bigger enhancements in lung function and signs and symptoms and a reduction in the demand for a little-acting bronchodilator with step-up therapy consisting of add-on extended-acting beta2- agonist (LABA) vs. add-on leukotriene-receptor antagonist (LTRA). However, extended-term trials recommend that clinical outcomes (e.g. exacerbations, hospitalisations, and rates of emergency treatment) are alike with these two kinds of add-on therapy.
&ampnbsp
A paper in the Fresh England Journal of Medicine reports the findings of two separate, two-year pragmatic trials, commissioned and predominantly funded by the U.K. Health Technologies …

Read full story • Comments { 0 }

Xolair for Seasonal Asthma

by on 21. Mar, 2011 in Health

There is excellent news and terrible news about Xolair (omalizumab), a newer asthma treat for kids.

The excellent news is that a fresh study in the Fresh England Journal of Medicine, Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-Megalopolis Children, found the Xolair 'further improved asthma control, nearly eliminated seasonal peaks in exacerbations, and reduced the demand for other medications to control asthma.' This was a study done on inner-megalopolis children, whose asthma is often dense to control....Glance at Complete Advertise (Source: About.com Pediatrics) More information: Full article...

Tags: Control, Inner, Health, england journal …

Read full story • Comments { 0 }
Page 1 of 212